91 related articles for article (PubMed ID: 2151392)
1. Reversal of cardiac hypertrophy and left ventricular function with the calcium antagonist felodipine in hypertensive patients.
Cerasola G; Cottone S; Nardi E; Fulantelli MA; Carone MB; D'Ignoto G
J Hum Hypertens; 1990 Dec; 4(6):703-8. PubMed ID: 2151392
[TBL] [Abstract][Full Text] [Related]
2. [Regression of hypertrophy following nitrendipine: effect on systolic and diastolic function].
Vogt M; Kreutz KU; Motz W; Strauer BE
Z Kardiol; 1989 Jul; 78(7):469-77. PubMed ID: 2528245
[TBL] [Abstract][Full Text] [Related]
3. [Left ventricular hypertrophy in hypertension: functional aspects].
Lombardo M; Zaini G; Colloca W; Belli C
G Ital Cardiol; 1987 Dec; 17(12):1039-44. PubMed ID: 2972580
[TBL] [Abstract][Full Text] [Related]
4. [Hypertensive hypertrophy of the left ventricle: its regression in hypertensive patients with different profiles of plasma renin activity, treated with enalapril].
Nogueira JB; Soares Ade O; da Costa JN
Rev Port Cardiol; 1990 Jun; 9(6):511-6. PubMed ID: 2147377
[TBL] [Abstract][Full Text] [Related]
5. [Regression of left heart hypertrophy in arterial hypertension: principles, experimental and clinical findings].
Klaus D
Z Kardiol; 1985; 74 Suppl 7():153-69. PubMed ID: 2936016
[TBL] [Abstract][Full Text] [Related]
6. Differential effects of felodipine and nifedipine on 24-h blood pressure and left ventricular mass.
Myers MG; Leenen FH; Tanner J
Am J Hypertens; 1995 Jul; 8(7):712-8. PubMed ID: 7546497
[TBL] [Abstract][Full Text] [Related]
7. Regression of left ventricular hypertrophy from systemic hypertension by gallopamil.
Franz IW; Behr U; Ketelhut R; Agrawal B
J Cardiovasc Pharmacol; 1987; 10 Suppl 10():S178-81. PubMed ID: 2455127
[TBL] [Abstract][Full Text] [Related]
8. [Echocardiographic analysis of anatomical and functional changes in the left heart ventricle during antihypertensive treatment with nicardipine].
Costantino G; Di Lorenzo L; Buonissimo S; Moccia D; Soro S; Ferrara LA; De Simone G
G Ital Cardiol; 1988 Aug; 18(8):644-8. PubMed ID: 2977346
[TBL] [Abstract][Full Text] [Related]
9. Effects of chronic administration of the fixed combination slow-release oxprenolol-chlorthalidone on left ventricular hypertrophy in hypertensive patients. Echocardiographic study.
Bertoni T; Alberti D; Peloso A; Francucci BM; De Ambroggi L
Int J Clin Pharmacol Ther Toxicol; 1988 Mar; 26(3):148-52. PubMed ID: 2970442
[TBL] [Abstract][Full Text] [Related]
10. Cardiovascular structural changes and calcium antagonist therapy in patients with hypertension.
Agabiti-Rosei E; Muiesan ML; Rizzoni D; Zulli R; Calebich S; Castellano M; Cavaliere G; Nordio G; Pasini F; Zuccato F
J Cardiovasc Pharmacol; 1994; 24 Suppl A():S37-43. PubMed ID: 7603076
[TBL] [Abstract][Full Text] [Related]
11. Contractile performance following regression of left ventricular hypertrophy in hypertensive patients.
Ibrahim MM; Emile H; Madkour MA; el-Said G
J Hypertens Suppl; 1985 Dec; 3(3):S465-7. PubMed ID: 2856768
[TBL] [Abstract][Full Text] [Related]
12. Ambulatory 24-hour blood pressure monitoring: correlation between blood pressure variability and left ventricular hypertrophy in untreated hypertensive patients.
Feola M; Boffano GM; Procopio M; Reynaud S; Allemano P; Rizzi G
G Ital Cardiol; 1998 Jan; 28(1):38-44. PubMed ID: 9493044
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the effects of nitrendipine and captopril on the regression of hypertensive left ventricular hypertrophy.
Wang LS; Bai MY
Chin Med J (Engl); 1991 Aug; 104(8):645-8. PubMed ID: 1833165
[TBL] [Abstract][Full Text] [Related]
14. Left ventricular hypertrophy regression in hypertensive patients treated with metoprolol.
Corea L; Bentivoglio M; Verdecchia P; Provvidenza M; Motolese M
Int J Clin Pharmacol Ther Toxicol; 1984 Jul; 22(7):365-70. PubMed ID: 6236155
[TBL] [Abstract][Full Text] [Related]
15. [Effect of sotalol on left ventricular mass and function in the hypertensive patient].
Gosse P; Durandet P; Roudaut R; Leherissier A; Vrancea F; Dallocchio M
Arch Mal Coeur Vaiss; 1991 Dec; 84(12):1823-6. PubMed ID: 1838917
[TBL] [Abstract][Full Text] [Related]
16. [Regression of hypertensive heart hypertrophy caused by chronic angiotensin-converting enzyme inhibition].
Motz W; Strauer BE
Z Kardiol; 1988 Jan; 77(1):53-60. PubMed ID: 2834885
[TBL] [Abstract][Full Text] [Related]
17. Is left ventricular systolic dysfunction in hypertensive patients with heart failure normalized by long-term antihypertensive therapy?
Hamada M; Ohtani T; Suzuki M; Lin M; Kobayashi T; Okayama H; Takezaki M; Hashida K; Abe M; Matsuoka H
J Cardiol; 1993; 23(2):165-75. PubMed ID: 8176628
[TBL] [Abstract][Full Text] [Related]
18. Left ventricular mass and cardiac function in patients with essential hypertension.
Grossman E; Oren S; Messerli FH
J Hum Hypertens; 1994 Jun; 8(6):417-21. PubMed ID: 8089826
[TBL] [Abstract][Full Text] [Related]
19. Differential effects of once-daily antihypertensive drugs on blood pressure, left ventricular mass and sympathetic activity: Nifedipine-GITS versus felodipine-ER versus enalapril.
Leenen FH; Myers MG; Joyner CD; Toal CB
Can J Cardiol; 2002 Dec; 18(12):1285-93. PubMed ID: 12518180
[TBL] [Abstract][Full Text] [Related]
20. Persistence of left ventricular hypertrophy is a stronger indicator of cardiovascular events than baseline left ventricular mass or systolic performance: 10 years of follow-up.
Muiesan ML; Salvetti M; Rizzoni D; Monteduro C; Castellano M; Agabiti-Rosei E
J Hypertens Suppl; 1996 Dec; 14(5):S43-9. PubMed ID: 9120684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
